Top 5 Stocks to Buy Now
→ Your book attached (From Profits Run) (Ad)tc pixel Free LUCY Stock Alerts

Innovative Eyewear (LUCY) Competitors

Innovative Eyewear logo
$0.76 -0.01 (-0.65%)
Closing price 06/25/2026 04:00 PM Eastern
Extended Trading
$0.76 -0.01 (-0.66%)
As of 06/25/2026 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

LUCY vs. MODD, IRIX, TMDIF, ICCM, and RVP

Should you buy Innovative Eyewear stock or one of its competitors? MarketBeat compares Innovative Eyewear with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Innovative Eyewear include Modular Medical (MODD), IRIDEX (IRIX), Titan Medical (TMDIF), IceCure Medical (ICCM), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry.

How does Innovative Eyewear compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Innovative Eyewear had 1 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company Overall Sentiment
Modular Medical Neutral
Innovative Eyewear Neutral

Modular Medical has a net margin of 0.00% compared to Innovative Eyewear's net margin of -272.42%. Innovative Eyewear's return on equity of -83.37% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
Innovative Eyewear -272.42%-83.37%-76.02%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Modular Medical has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.66, indicating that its share price is 166% more volatile than the broader market.

Innovative Eyewear has higher revenue and earnings than Modular Medical. Innovative Eyewear is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
Innovative Eyewear$2.66M1.83-$7.59M-$1.69N/A

Summary

Innovative Eyewear beats Modular Medical on 8 of the 12 factors compared between the two stocks.

How does Innovative Eyewear compare to IRIDEX?

Innovative Eyewear (NASDAQ:LUCY) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

In the previous week, Innovative Eyewear and Innovative Eyewear both had 2 articles in the media. Innovative Eyewear's average media sentiment score of 0.00 equaled IRIDEX'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Eyewear
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IRIDEX
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

IRIDEX has a net margin of -6.23% compared to Innovative Eyewear's net margin of -272.42%. Innovative Eyewear's return on equity of -83.37% beat IRIDEX's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative Eyewear-272.42% -83.37% -76.02%
IRIDEX -6.23%-1,204.74%-11.16%

IRIDEX has higher revenue and earnings than Innovative Eyewear. IRIDEX is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$2.66M1.83-$7.59M-$1.69N/A
IRIDEX$52.67M0.39-$4.44M-$0.19N/A

IRIDEX has a consensus price target of $3.00, indicating a potential upside of 154.24%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts plainly believe IRIDEX is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
IRIDEX
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 8.6% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Innovative Eyewear has a beta of 2.66, meaning that its share price is 166% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

Summary

IRIDEX beats Innovative Eyewear on 10 of the 14 factors compared between the two stocks.

How does Innovative Eyewear compare to Titan Medical?

Innovative Eyewear (NASDAQ:LUCY) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Innovative Eyewear has a beta of 2.66, suggesting that its share price is 166% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

Titan Medical has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$2.66M1.83-$7.59M-$1.69N/A
Titan Medical$17.63M1.05$6.95M$0.053.23

In the previous week, Innovative Eyewear had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Innovative Eyewear and 0 mentions for Titan Medical. Innovative Eyewear's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company Overall Sentiment
Innovative Eyewear Neutral
Titan Medical Neutral

Titan Medical has a net margin of 0.00% compared to Innovative Eyewear's net margin of -272.42%. Titan Medical's return on equity of -82.31% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative Eyewear-272.42% -83.37% -76.02%
Titan Medical N/A -82.31%-51.47%

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Titan Medical beats Innovative Eyewear on 7 of the 13 factors compared between the two stocks.

How does Innovative Eyewear compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

In the previous week, IceCure Medical had 13 more articles in the media than Innovative Eyewear. MarketBeat recorded 15 mentions for IceCure Medical and 2 mentions for Innovative Eyewear. IceCure Medical's average media sentiment score of 0.19 beat Innovative Eyewear's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Innovative Eyewear
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Innovative Eyewear has a net margin of -272.42% compared to IceCure Medical's net margin of -441.60%. Innovative Eyewear's return on equity of -83.37% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-441.60% -211.73% -119.13%
Innovative Eyewear -272.42%-83.37%-76.02%

IceCure Medical has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.66, suggesting that its stock price is 166% more volatile than the broader market.

Innovative Eyewear has lower revenue, but higher earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M5.84-$15.06M-$7.21N/A
Innovative Eyewear$2.66M1.83-$7.59M-$1.69N/A

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IceCure Medical currently has a consensus price target of $62.70, suggesting a potential upside of 793.16%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe IceCure Medical is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

IceCure Medical and Innovative Eyewear tied by winning 8 of the 16 factors compared between the two stocks.

How does Innovative Eyewear compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

Retractable Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.66, indicating that its stock price is 166% more volatile than the broader market.

In the previous week, Innovative Eyewear had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Innovative Eyewear and 0 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company Overall Sentiment
Retractable Technologies Neutral
Innovative Eyewear Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Retractable Technologies has higher revenue and earnings than Innovative Eyewear. Retractable Technologies is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$37.15M0.56-$7.01M-$0.21N/A
Innovative Eyewear$2.66M1.83-$7.59M-$1.69N/A

Retractable Technologies has a net margin of -41.11% compared to Innovative Eyewear's net margin of -272.42%. Retractable Technologies' return on equity of -17.15% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
Innovative Eyewear -272.42%-83.37%-76.02%

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Retractable Technologies beats Innovative Eyewear on 8 of the 13 factors compared between the two stocks.

Get Innovative Eyewear News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUCY vs. The Competition

Export
MetricInnovative EyewearMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.90M$8.41B$6.61B$12.27B
Dividend YieldN/A2.53%2.67%5.87%
P/E Ratio-0.4515.7126.0223.97
Price / Sales1.837.09542.89101.46
Price / CashN/A17.1646.3353.91
Price / Book0.453.2710.516.32
Net Income-$7.59M$226.25M$3.57B$337.22M
7 Day Performance-5.00%-0.65%0.79%-1.24%
1 Month Performance-25.49%-2.96%0.21%-0.63%
1 Year Performance-62.93%0.62%30.81%27.95%

Innovative Eyewear Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUCY
Innovative Eyewear
1.0674 of 5 stars		$0.76
-0.7%		N/A-64.5%$4.90M$2.66MN/A9
MODD
Modular Medical
0.6793 of 5 stars		$4.54
-7.5%		N/A-83.0%$21.18MN/AN/A20
IRIX
IRIDEX
2.0371 of 5 stars		$1.19
+0.3%		$3.00
+151.3%		+25.1%$20.61M$52.67MN/A120
TMDIF
Titan Medical
N/A$0.18
-7.2%		N/A-47.0%$20.44M$17.63MN/A50
ICCM
IceCure Medical
3.5957 of 5 stars		$6.91
+224.6%		$62.70
+807.0%		-77.1%$20.28M$3.38MN/A60

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:LUCY) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
The EPA just put a kill switch on Elon’s empire
A federal EPA permit expires January 2, 2027 - and if Elon Musk's Colossus supercomputer loses power that day,...
Behind the Markets | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
Grab it and keep it
Simple Options Trading For Beginners is currently available as a free download - a guide normally priced at $2...
Profits Run | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel